Platform architecture
The NM-mRNA approach brings payload, composition, process and transfer decisions together in an application-focused architecture. The long-term objective is to expand access to mRNA product systems.
DK / INSTITUTIONAL
Driessen-Kerr connects molecular biology, formulation, process, characterization and transfer in product systems focused on real-world applications.
The NM-mRNA approach brings payload, composition, process and transfer decisions together in an application-focused architecture. The long-term objective is to expand access to mRNA product systems.
EPITIDE™ belongs to the precision-nutrition program, separate from NM-mRNA product systems. Its formulation and ingredient science are presented in a dedicated partner pathway.
Define the problem and separate published mechanisms from the proposed application.
Connect composition, critical attributes, process, stability and analytical method.
Choose assays that can confirm or refute each product hypothesis.
Define partner, capacity, comparability, documentation and regulatory route for each program.
Our ambition is to make science-led product systems more accessible. Each opportunity starts with the partner's application and technical context.
Driessen-Kerr engages with research, development, manufacturing and distribution organizations according to each partnership's application and scope.
Specific institutional information is addressed directly with qualified counterparts.
Choose your area of interest and share your context. Technical scope and relevant materials are addressed through institutional dialogue.